单次和连续二周口服苯脂丙脯酸治疗心功能衰竭血流动力学和临床观察
Clinical and hemodynamic studies on effect of single dose and 2-weeks continuous oral enalapril in patients with heart failure
-
摘要: 为探讨长效血管紧张素转换酶抑制剂苯脂丙脯酸在心衰患者的血流动力学作用,本研究对10例慢性心衰患者(冠心病6例、高心病2例、心肌病2例),口服苯脂丙脯酸10—20mg,1日1次,连用2周。首次口服后作血流动力学观察。结果表明:用药后4小时,平均动脉压下降18.29%。CVP下降40.35%,mPAP下降23.96%,PCWP下降41.2%,SVR和PVR分别下降39.96%(P均<0.001)。心排指数上升44.16%(P<0.001),1次口服作用可持续24小时以上。连续口服2周,平均血压下降18~20%(P<0.01),患者症状和体征明显改善,心功能改善,未发现明显副作用。本研究结果提示:苯脂丙脯酸对慢性心功能衰竭的治疗是有效的,能获得即刻和长期的血流动力学改善,可单独或联合应用于心衰治疗。Abstract: Clinical and hemodynamic studies were carried out with the purpose of evaluating the effects of enalapril in the treatment of chronic heart failure. Enalapril 10—20 mg was given once a day to 10 patients with moderate to severe congestive heart failure(coronary 6,hypertensive heart disease 2 and idiopathic congestive cardiomyopathy.). Hemodynamic studies were done on the first day after drug administration,the same daily dose was maitained for 2 weeks. The results showed a 18.29% decrease in mean BP(p<0.01),40.4% in CVP,23.9% in mPAP,41.2% in PCWP,39.9% and 41.3% in SVR and PVR respectively(P<0.001).Cardiac index increased 44.16%(P<0.001).The theraputic action maintained and lasted for more than 24 hours by one dose.No further drop of BP 2 weeks later.Six patients primarily in NYHA class Ⅲ and 2 in Class Ⅳ improved to class Ⅱ.No severe side effects were found. The results showed that enalapril was well tolerated in single dose as well as in 2 weeks continous therapy,showing both hemodynamic and subjective sympton improvement.
下载: